The Department of Health and Aged Care announce new credentialing requirements announced as pharmacists prepare to take on aged care roles.

A recent systematic review has reignited debate about what happens when patients stop taking GLP-1 RAs and related incretin therapies.

Expert advice for applying the right dosage instructions on dispensed medicine labels on a case-by-case basis.

With New South Wales recently expanding its pharmacy prescribing trial to include skin conditions, could other jurisdictions soon follow?

The Therapeutic Goods Administration has announced shortages on several brands of HIV PrEP medicines, concerning healthcare professionals.

PSA has called for transformational change in the pharmacy profession within five years. So what could that future state look like? ‘By 2023, pharmacists within...